Can TRIF/TICAM-1 Dependent Pathway Be Target Pathway in Lumbar Intervertebral Disc Degeneration?
Preprint
- 1 January 2022
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
Background: The aims of the current study were to enlighten role of the TIR-domain-containing adapter-inducing interferon-β (TRIF) dependent pathway in intervertebral disc degeneration (IVD). Methods: 88 adult male patients with lower back pain (LBP) (+/- radicular pain) were further evaluated MRI and operated with surgical indication for lumbar disc herniation (LDH). Preoperatively, patients were classified according to the Modic changes (MC), usage of non-steroid anti-inflammatory drugs (NSAIDs) and the presence of radicular pain additional to the LBP. Results: The 88 patients ranged in age from 19 to 75 years (mean: 47.3 ± 19.6 age). 28 of the patients were evaluated as MC I (31.8%), 40 as MC II (45.4%), and 20 as MC III (22.7%). In majority of the patients (81.8%) radicular pain had accompanying to their LBP, while 16 patients (18.1%) had only LBP. Predominantly, 55.6% of all patients were using NSAIDs. The levels of all adapter molecules were the highest in MC I group and the lowest in MC III group. The levels of IRF3, TICAM1, TICAM2, NF-kB p65, TRAF6, TLR4 increased significantly in MC I group when compare to MC II and MC III group. Regarding the use of NSAIDs and accompanying radicular pain to the lower back pain, variances for each adapter molecule did not show a statistically significant difference. Conclusions: As a result of assessing the consequences, current study clearly showed that the TRIF dependent pathway has a crucial role in the degeneration process in human lumbar disc specimen for the first time. Ethics: The study was approved by the Institutional Review Boards of Istanbul University Cerrahpasa. The approval number is 13/04/2017-142246. All patients gave their written informed consent to participate in the study and for publication before the surgery. The privacy rights of human subjects were always observed Funding Information: This study was funded by Scientific Research Projects Coordination Unit of Istanbul University Cerrahpasa; Project number: 25405 Conflict of Interests: This study was funded by Scientific Research Projects Coordination Unit of Istanbul University Cerrahpasa; Project number: 25405. On behalf of all authors, the corresponding author states that there is no other conflict of interest.Keywords
This publication has 25 references indexed in Scilit:
- Vertebral Endplate Changes Are Not Associated with Chronic Low Back Pain among Southern European Subjects: A Case Control StudyAmerican Journal of Neuroradiology, 2012
- Assessment of Ankylosing Spondylitis Criteria in Patients with Chronic Low Back Pain and Vertebral Endplate Modic I Signal ChangesThe Journal of Rheumatology, 2010
- Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissuesArthritis & Rheumatism, 2010
- Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathwayMolecular Immunology, 2010
- Molecular mechanisms involved in intervertebral disc degeneration and potential new treatment strategiesBioscience Horizons, 2009
- Tumor Necrosis Factor-Immunoreactive Cells and PGP 9.5-Immunoreactive Nerve Fibers in Vertebral Endplates of Patients With Discogenic Low Back Pain and Modic Type 1 or Type 2 Changes on MRISpine, 2006
- TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferonsThe International Journal of Biochemistry & Cell Biology, 2005
- Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling PathwayScience, 2003
- TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β inductionNature Immunology, 2003
- Differential involvement of IFN- in Toll-like receptor-stimulated dendritic cell activationInternational Immunology, 2002